Significant Ownership of ORAMED PHARMACEUTICALS INC.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for ORAMED PHARMACEUTICALS INC. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Avraham Gabay - Avraham Gabay, Chief Financial Officer
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow ORAMED PHARMACEUTICALS INC. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from ORAMED PHARMACEUTICALS INC.
Significant Ownership of ORAMED PHARMACEUTICALS INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LFWD | Lifeward Ltd. | Ordinary Shares, no par value | 50% | 1,528,221 | Oramed Pharmaceuticals Inc. | 25 Mar 2026 | |||
| DRTS | Alpha Tau Medical Ltd. | Ordinary shares, no par value | 20% | $37,250,719 | 14,110,121 | Oramed Pharmaceuticals Inc. | 24 Apr 2025 | ||
| SCLX | Scilex Holding Company | Common Stock par value $0.0001 per share | 9.9% | $146,543 | -$2,953,457 | 732,717 | -95% | Oramed Pharmaceuticals Inc. | 31 Mar 2025 |
| SCLX | Scilex Holding Co | Common Stock, par value $0.0001 per share | 4.9% | $5,438,249 | -$4,921,820 | 437,510 | -48% | Oramed Pharmaceuticals Inc. | 31 Dec 2025 |
| NNDM | Nano Dimension Ltd. | Ordinary Shares, par value NIS 5.00 per share | 3.3% | $9,975,577 | -$11,890,000 | 6,879,708 | -54% | Oramed Pharmaceuticals Inc. | 20 Jul 2026 |
Schedules 13D/G Reported by ORAMED PHARMACEUTICALS INC.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.